바이오마린제약(주)
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership3,010,308 shares
Latest Disclosed Value $ 170,052,299
Millennium Management Llc ownership in BMRN / BioMarin Pharmaceutical Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 3,010,308 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $170,052,299 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,037,616 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -0.90% during the quarter.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 58,000 of underlying shares valued at $3,276,420 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,010,308 -27,308 -0.90 170,052 -5.80 0.0708
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,037,616 410,406 15.62 180,526 26.87 0.0759
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,627,210 -207,145 -7.31 142,290 -8.67 0.0607
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,834,355 2,159,083 319.74 155,804 226.40 0.0752
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 675,272 267,116 65.44 47,735 77.93 0.0254
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 408,156 -234,524 -36.49 26,828 -40.61 0.0131
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 642,680 -476,044 -42.55 45,174 -50.95 0.0214
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,118,724 -1,158,455 -50.87 92,105 -53.69 0.0427
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,277,179 1,108,824 94.90 198,889 76.55 0.0850
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,168,355 904,404 342.64 112,653 382.37 0.0487
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 263,951 -66,456 -20.11 23,354 -18.45 0.0118
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 330,407 792 0.24 28,640 -10.65 0.0141
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 329,615 -455,835 -58.03 32,052 -60.57 0.0184
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 785,450 -1,088,822 -58.09 81,286 -48.84 0.0450
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,874,272 348,269 22.82 158,882 25.64 0.0940
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,526,003 224,011 17.21 126,460 25.98 0.0785
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,301,992 593,956 83.89 100,384 60.47 0.0532
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 708,036 -140,452 -16.55 62,555 -4.61 0.0318
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 848,488 807,552 1,972.72 65,580 1,819.79 0.0393
2021-08-16 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,936 -204,255 -83.30 3,416 -81.55 0.0021
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 245,191 -226,302 -48.00 18,514 -55.22 0.0132
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 471,493 -37,571 -7.38 41,345 6.75 0.0299
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 509,064 374,732 278.96 38,730 133.75 0.0477
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 134,332 -94,130 -41.20 16,569 -14.17 0.0227
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 228,462 -381,353 -62.54 19,305 -62.56 0.0434
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 609,815 357,766 141.94 51,560 203.51 0.0645
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 252,049 -159,380 -38.74 16,988 -51.79 0.0269
2019-08-15 2019-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 411,429 236,551 135.27 35,239 126.85 0.0530
2019-08-14 2019-06-30 13F VOXX INTL CL A 09061G101 161,765 -135,200 1,186
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 174,878 68,586 64.53 15,534 71.63 0.0232
2019-02-15 2018-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 106,292 -228,550 -68.26 9,051 -72.13 0.0141
2019-02-14 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 106,292 9,051
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 334,842 -254,808 -43.21 32,470 -41.54 0.0398
2018-08-14 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 589,650 -55,750 -8.64 55,545 6.16 0.0725
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 645,400 10,536 1.66 52,323 -7.57 0.0698
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 634,864 160,132 33.73 56,611 28.13 0.0781
2017-11-14 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 474,732 -410,262 -46.36 44,183 -45.03 0.0673
2017-08-14 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 884,994 882,017 29,627.71 80,375 30,695.02 0.1434
2017-05-15 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,977 2,977 261 0.0005
2017-02-14 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -337,301 -100.00 0 -100.00
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 337,301 275,632 446.95 31,207 550.42 0.0523
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 61,669 -111,037 -64.29 4,798 -66.32 0.0110
2016-05-16 2016-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 172,706 -777,441 -81.82 14,245 -85.69 0.0356
2016-02-16 2015-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 950,147 218,723 29.90 99,537 29.21 0.2093
2015-11-16 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 731,424 -304,218 -29.37 77,034 -45.62 0.1492
2015-08-14 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,035,642 -158,000 -13.24 141,655 -4.77 0.2679
2015-05-15 2015-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,193,642 277,210 30.25 148,752 79.55 0.2768
2015-02-17 2014-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 916,432 229,533 33.42 82,845 67.14 0.1755
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 686,899 -702,133 -50.55 49,567 -42.64 0.1254
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,389,032 1,356,725 4,199.48 86,412 3,820.69 0.2393
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,307 -916,023 -96.59 2,204 -96.70 0.0064
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 948,330 893,522 1,630.28 66,715 1,586.85 0.2105
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 54,808 -183,357 -76.99 3,955 -70.21 0.0127
2013-08-14 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 238,165 238,165 13,275 0.0407
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 58,000 -63.29 3,276 -65.11 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 158,000 41.20 9,390 54.93 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 111,900 6,061 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 100,000 146.91 7,069 165.55 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 40,500 -55.98 2,662 -58.83 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 92,000 94.92 6,467 66.44 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 47,200 -85.96 3,886 -86.77 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 336,300 130.03 29,372 108.37 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 146,200 130.60 14,097 151.31 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 63,400 217.00 5,610 223.66 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 20,000 -73.44 1,734 -76.33 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 75,300 7,322 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 10,000 848 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 20,000 1,546 n/a n/a n/a
2021-05-17 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 52,000 4,560 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 50,000 6,167 n/a n/a n/a
2020-05-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 50,000 -75.00 4,228 -68.64 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 200,000 -11.11 13,480 -30.05 n/a n/a n/a
2019-08-15 2019-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 225,000 12.50 19,271 8.47 n/a n/a n/a
2019-05-14 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 200,000 17,766 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 44,600 4.94 2,775 -7.19 n/a n/a n/a
2014-02-14 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 42,500 7.87 2,990 5.17 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 39,400 2,843 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 20,000 38.89 1,189 52.50 n/a n/a n/a
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 14,400 8.27 780 6.57 n/a n/a n/a
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 13,300 98.51 731 54.55 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 6,700 -19.28 474 -13.21 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 8,300 -87.92 546 -88.71 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 68,700 401.46 4,829 328.39 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 13,700 -56.51 1,128 -59.03 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 31,500 -50.00 2,751 -54.71 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 63,000 159.26 6,074 182.51 n/a n/a n/a
2023-11-14 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 24,300 2,150 n/a n/a n/a
2023-08-14 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 125,300 12,184 n/a n/a n/a
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 15,000 1,850 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 3,900 266 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.